← Back to Search

Animal-assisted Therapy

Animal-Assisted Interaction for Hospitalized Children

N/A
Recruiting
Led By Nancy R Gee, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of treatment (about 5 days), 1 month after treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of an AAI to conversation and usual care on children's mental health.

Who is the study for?
This trial is for English-speaking children and adolescents aged 8-17 who are hospitalized and can understand the study, as well as adults over 18. Participants must have a working phone, email, or address for follow-up and be expected to stay in the hospital for at least five more days.
What is being tested?
The study is testing if therapy dogs (animal-assisted intervention) can help reduce depression, anxiety, and loneliness better than just talking to someone or receiving standard care. It also looks at how these interventions might affect hospital stays and healthcare costs.
What are the potential side effects?
There are generally no direct medical side effects from animal-assisted interactions or conversational interactions; however, there may be risks of allergic reactions or fear/phobia responses in some individuals when interacting with animals.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of treatment (about 5 days), 1 month after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of treatment (about 5 days), 1 month after treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety
Mental Depression
Change in Loneliness
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Conversational interactionExperimental Treatment1 Intervention
Conversational interaction with the participants and the dog-handler
Group II: Animal-assisted interactionExperimental Treatment1 Intervention
A dog-handler team will visit participants in their hospital room
Group III: Treatment as usualActive Control1 Intervention
Participants will received the regular services currently being received in the hospital
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Animal-assisted interaction
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Purina Mills, IncUNKNOWN
Virginia Commonwealth UniversityLead Sponsor
719 Previous Clinical Trials
22,895,776 Total Patients Enrolled
Nancy R Gee, PhDPrincipal InvestigatorVirginia Commonwealth University

Media Library

Animal-assisted interaction (Animal-assisted Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05551156 — N/A
Hospitalized Children Research Study Groups: Animal-assisted interaction, Treatment as usual, Conversational interaction
Hospitalized Children Clinical Trial 2023: Animal-assisted interaction Highlights & Side Effects. Trial Name: NCT05551156 — N/A
Animal-assisted interaction (Animal-assisted Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05551156 — N/A
~25 spots leftby Dec 2025